Switch to:
Onyx Pharmaceuticals, Inc. (NAS:ONXX)
EV/EBIT
0.00 (As of Today)

EV/EBIT ratio is calculated as enterprise value divided by its EBIT. As of today, Onyx Pharmaceuticals, Inc.'s enterprise value is $0.0 Mil. Onyx Pharmaceuticals, Inc.'s operating income for the trailing twelve months (TTM) ended in Jun. 2013 was $-186.6 Mil. Therefore, Onyx Pharmaceuticals, Inc.'s EV/EBIT ratio for today is 0.00.

ONXX' s 10-Year EV/EBIT Range
Min: 0   Max: 0
Current: 0

ONXX's EV/EBITis ranked higher than
55% of the 1337 Companies
in the Global Biotechnology industry.

( Industry Median: 9999.00 vs. ONXX: 0.00 )

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt). Onyx Pharmaceuticals, Inc.'s enterprise value for the quarter that ended in Jun. 2013 was $5,763.8 Mil. Onyx Pharmaceuticals, Inc.'s Operating Income for the trailing twelve months (TTM) ended in Jun. 2013 was $-186.6 Mil. Onyx Pharmaceuticals, Inc.'s Earnings Yield (Joel Greenblatt) for the quarter that ended in Jun. 2013 was -3.24%.


Definition

Onyx Pharmaceuticals, Inc.'s EV/EBIT for today is calculated as:

EV/EBIT=Enterprise Value (Today)/Operating Income (TTM)
=0.000/-186.569
=0.00

Onyx Pharmaceuticals, Inc.'s current Enterprise Value is $0.0 Mil.
Onyx Pharmaceuticals, Inc.'s Operating Income for the trailing twelve months (TTM) ended in Jun. 2013 was -72.352 (Sep. 2012 ) + -38.211 (Dec. 2012 ) + -28.473 (Mar. 2013 ) + -47.533 (Jun. 2013 ) = $-186.6 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

This is a more accurate valuation of companies' operation because it consider the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt).

Onyx Pharmaceuticals, Inc.'s Earnings Yield (Joel Greenblatt) for the quarter that ended in Jun. 2013 is calculated as:

Earnings Yield (Joel Greenblatt) (Q: Jun. 2013 )=Operating Income (TTM)/Enterprise Value (Q: Jun. 2013 )
=-186.569/5763.84982
=-3.24 %

Onyx Pharmaceuticals, Inc.'s Enterprise Value for the quarter that ended in Jun. 2013 was $5,763.8 Mil.
Onyx Pharmaceuticals, Inc.'s Operating Income for the trailing twelve months (TTM) ended in Jun. 2013 was -72.352 (Sep. 2012 ) + -38.211 (Dec. 2012 ) + -28.473 (Mar. 2013 ) + -47.533 (Jun. 2013 ) = $-186.6 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Related Terms

Enterprise Value, Operating Income, Earnings Yield (Joel Greenblatt)


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Onyx Pharmaceuticals, Inc. Annual Data

Dec03Dec04Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12
ev2ebit 0.000.000.000.000.000.0070.570.0024.610.00

Onyx Pharmaceuticals, Inc. Quarterly Data

Mar11Jun11Sep11Dec11Mar12Jun12Sep12Dec12Mar13Jun13
ev2ebit 0.000.000.0024.6122.12117.440.000.000.000.00
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK